Neurotoxins: Evidence for Prevention

June 2017 | Volume 16 | Issue 6 | Supplement Individual Articles | 87 | Copyright © June 2017

Shannon Humphrey MD

Carruthers & Humphrey Cosmetic Dermatology, Vancouver, BC Canada Department of Dermatology, University of British Columbia, Vancouver, BC Canada

Figure3via controlled trials: repeated treatment cycles with BoNTA for facial rhytides over a long period of time not only prevent new wrinkle development but also improve skin texture and appear- ance and lead to progressive wrinkle reduction of established rhytides. Clinically, these reports and observations translate to better aesthetic outcomes and much higher levels of patient satisfaction.


The author has not disclosed any con icts of interest.


  1. American Society of Plastic Surgeons (2015). 2014 Plastic Surgery Statistics Report. Available at: Accessed September 7, 2016. 
  2. Carruthers A, Carruthers J. Botulinum toxin type A: History and current cosmetic use in the upper face. Semin Cutan Med Surg. 2001;20:71-84. 
  3. Bowler PJ. Dermal and epidermal remodeling using botulinum toxin type A for facial, non reducible, hyperkinetic lines: Two case studies. J Cosmet Dermatol. 2008;7:241-4. 
  4. Binder WJ. Long-term effects of botulinum toxin type A (Botox) on facial lines: A comparison in identical twins. Arch Facial Plast Surg. 2006;8:426–31. 
  5. Dailey RA, Philip A, Tardie G. Long-term treatment of glabellar rhytides using onabotulinumtoxina. Dermatol Surg. 2011;37:918-28. 
  6. Rivkin A, Binder WJ. Long-term effects of onabotulinumtoxinA on facial lines: a 19-year experience of identical twins. Dermatol Surg. 2015;41 Suppl 1:S64-6. 
  7. Koerte IK, Schroeder AS, Fietzek UM, Borggraefe I, et al. Muscle atrophy beyond the clinical effect after a single dose of OnabotulinumtoxinA injected in the procerus muscle: a study with magnetic resonance imaging. Dermatol Surg. 2013;39:761-5. 
  8. Bonaparte JP, Ellis D. Skin biomechanical changes after injection of onabotulinum toxin A: Prospective assessment of elasticity and pliability. Otolaryngol Head Neck Surg. 2014;150:949-55. 
  9. Luebberding S, Krueger N, Kerscher M. Mechanical properties of human skin in vivo: a comparative evaluation in 300 men and women. Skin Res Technol. 2014;20:127-35. 
  10. Bonaparte JP, Ellis D. Alterations in the elasticity, pliability, and viscoelastic properties of facial skin after injection of onabotulinum toxin A. JAMA Facial Plast Surg. 2015;17:256-63. 
  11. Uitto J. Molecular pathology of collagen in cutaneous diseases. Adv Dermatol. 1991;6:265–86. 
  12. Kim KH, Geronemus RG. Non-ablative laser and light therapies for skin rejuvenation. Arch Facial Plast Surg. 2004;6:398–409. 
  13. El-Domyati M, Attia SK, El-Sawy AE, Moftah NH, et al. The use of Botulinum toxin-a injection for facial wrinkles: A histological and immunohistochemical evaluation. J Cosmet Dermatol. 2015;14:140-4. 
  14. Chang SP, Tsai HH, Chen WY, Lee WR, et al. The wrinkles soothing effect on the middle and lower face by intradermal injection of botulinum toxin type A. Int J Dermatol. 2008;47:1287–94. 
  15. Shah AR. Use of intradermal botulinum toxin to reduce sebum production and facial pore size. J Drugs Dermatol. 2008;7:847–50. 
  16. Fernandes D, Signorini M. Combating photoaging with percutaneous collagen induction. Clin Dermatol. 2008;26:192–9. 
  17. Kapoor R, Shome D, Jain V, et al. Facial rejuvenation after intradermal botulinum toxin: Is it really the botulinum toxin or is it the pricks? Dermatol Surg. 2010;36(Suppl 4):2098–105. 
  18. Oh S, Lee Y, Seo YJ, et al. The potential effect of botulinum toxin Type A on human dermal broblasts: An in vitro study Dermatol Surg. 2012; 38:1689–1694. 


Shannon Humphrey MD E-mail:................................................... [email protected]